Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
12/2005
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267094 glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens
12/01/2005CA2566934A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
11/2005
11/30/2005EP1599443A1 Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament
11/30/2005EP1159278B1 Inhibitors of aspartyl protease
11/24/2005WO2005111134A2 Method of nucleating a polyolefin composition with acetal-based compounds
11/24/2005US20050258400 Nematic or cholesteric or chiral-smectic; high absolute values of dielectric anisotropy combined with a favorable ratio of viscosity to clearing point; light- and UV-stable, and also thermally stable; high voltage holding ratio
11/24/2005DE102004022728A1 Fluorierte Phenanthrene und ihre Verwendung in Flüssigkristallmischungen Fluorinated phenanthrenes and their use in liquid crystal mixtures
11/23/2005EP1597322A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/17/2005WO2005108479A2 Acetal-based compositions
11/17/2005WO2005108338A1 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
11/17/2005US20050255055 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine
11/16/2005EP1594835A2 Method of preparation of heterocyclic molecules with pharmaceutical pharmaceutical excipient cosmeceutical agrochemical and industrial uses
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/10/2005WO2005105776A1 Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both
11/10/2005WO2005105775A1 Method of recovering lactide from polylactic acid or derivative thereof
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005US20050250943 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists
11/10/2005CA2566196A1 Arylsulfonyl benzodioxanes useful for modulating the 5-ht6 receptor, the 5-ht2a receptor or both
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP0918775B1 Phenyl-substituted cyclic ketoenol
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1226296C Process for preparing sifatadin
11/08/2005US6963012 2-amino-2-[4-(3-benzyloxyphenoxy)-2-chlorophenyl]propyl-1,3-propanediol for example; treating autoimmune diseases such as rheumatoid arthritis, transplant rejection, psoriasis, dermatitis
11/08/2005US6962938 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
11/08/2005US6962929 Drugs such as 4-(N,N-Dimethylamino)-1-pentafluorophenyl-sulfonamidobenzene and/or prodrugs, used as anticarcinogenic agents, microbiocides or bactericides; tubulin inhibitors
11/08/2005US6962767 Acetal compound, polymer, resist composition and patterning process
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/02/2005CN1690038A Process for producing 2-benzoyloxyacetaldehyde derivative
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
10/2005
10/27/2005WO2005100345A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005WO2005100301A1 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
10/27/2005WO2004016213A3 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
10/27/2005US20050239928 Dibenzylidenesorbitol derivatives made by condensation, acetalization, and cyclization of benzaldehyde derivative and mono-, di-, or tri-acetal substituted alditol; nucleating, gelling, or clarifying agents; thickeners; plastic and/or polypropylene additive
10/27/2005US20050239926 Method of nucleating a polyolefin composition with acetal-based compounds
10/27/2005US20050239862 Amino ceramide-like compounds and therapeutic methods of use
10/27/2005US20050239799 1-phenyl-4-benzylpiperazines dopamine receptor subtype
10/27/2005CA2562401A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/26/2005EP1589016A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005CN1688576A Thiophene compounds
10/26/2005CN1688568A Process for the production of gamma-keto acetals
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097773A1 1,1’-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/20/2005US20050234265 2-aminomethyl-5-tert-butyl-3-phenylphenol; antimalaria; used against protozoa of the genus Plasmodium, particularly emerging strains of drug-resistant Plasmodia
10/20/2005US20050234246 Process for producing 2-benzoyloxyacetaldehyde derivative
10/20/2005US20050234121 coating formulations and polymers that utilize a dioxanone containing composition or fatty acid derivative
10/20/2005CA2560648A1 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1585757A2 Peptide deformylase inhibitors
10/19/2005EP1585742A1 Substituted benzoyl derivatives uses as herbicides
10/19/2005EP1585725A2 Compounds which mimic the chemical and biological properties of discodermolide
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005CN1683366A Fatty chain end group diamine substituted hypocrellin derivative and its preparing method and use
10/13/2005WO2005095378A2 Vegetable based dioxanone derivatives, synthesis and uses thereof
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005US20050228181 Serotonin receptor antagonists; nervous system disorders, R)-4-(2,3-dihydro-1,4-benzodioxin-5-yl)- beta -methyl-1-piperazineethanol
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227951 Verification of translation
10/13/2005US20050224756 3,3,4,4-Tetrafluorocyclopentane compounds, used as components of liquid crystal media
10/13/2005CA2560776A1 Vegetable based dioxanone derivatives, synthesis and uses thereof
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005CN1681775A N-hydroxyformamidine derivative
10/12/2005CN1680387A Preparation of hydroxy benzoic propionate
10/12/2005CN1680383A Indicated tetraodotoxin, preparation and use thereof
10/12/2005CN1680382A Preparation of tetraodotoxin by two-step resin method and tetraodotoxin preparation thereof
10/12/2005CN1680363A Process for the preparation of 2-(6-substituted-1,-3-dioxane-4-yl) acetic acid derivatives
10/12/2005CN1680362A 5-acrylic oxo-trimethylene carbonate and its preparation and use
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/11/2005US6953812 Carboxy and amide containing compound suitable for treatment and/or prevention of diseases wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, diabetes, disorders of the lipid metabolism, such as dyslipidemia
10/06/2005US20050222434 Acid-sensitive compounds, their preparation and uses
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050222244 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
10/06/2005US20050222216 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581474A1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
10/05/2005CN1678558A Method for producing aldehydes by means of hydroformylation of olefinically unsaturated compounds, said hydroformylation being catalyzed by unmodified metal complexes in the presence of cyclic carboni
10/05/2005CN1678557A Method for hydroformylation of olefinically unsaturated compounds, in particular the hydroformylation of olefin in the presence of cyclic carbonic acid esters
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/04/2005US6951882 treating obesity or a sleep/wake disorder mediated by orexin-2; antagonists
09/2005
09/28/2005EP1578359A2 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
09/28/2005CN1220690C 5-benzamido-1, 3-dioxide cyclo group compound and preparation process thereof, and use in preparing protein kinase C inhibito medicine
09/27/2005US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005072681A3 Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain.
09/22/2005US20050209489 Method for producing aldehydes by means of hydroformylation of olefinically unsaturated compounds, said hydroformylation being catalyzed by unmodified metal complexes in the presence of cyclic carbonic acid esters
09/22/2005US20050209283 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
09/21/2005EP1577286A1 Perfluoroallyloxy compound and liquid-crystal composition containing the compound
09/21/2005EP1575495A2 Compounds and methods
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 103